194 related articles for article (PubMed ID: 31412007)
21. Histologic and Oncologic Outcomes Following Liver Mass Resection With Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Germ Cell Tumor.
Pietzak EJ; Assel M; Becerra MF; Tennenbaum D; Feldman DR; Bajorin DF; Motzer RJ; Bosl GJ; Carver BS; Sjoberg DD; Sheinfeld J
Urology; 2018 Aug; 118():114-118. PubMed ID: 29704586
[TBL] [Abstract][Full Text] [Related]
22. Primary Robot-assisted Retroperitoneal Lymph Node Dissection for Men with Nonseminomatous Germ Cell Tumor: Experience from a Multi-institutional Cohort.
Taylor J; Becher E; Wysock JS; Lenis AT; Litwin MS; Jipp J; Langenstroer P; Johnson S; Bjurlin MA; Tan HJ; Lane BR; Huang WC
Eur Urol Focus; 2021 Nov; 7(6):1403-1408. PubMed ID: 32682794
[TBL] [Abstract][Full Text] [Related]
23. Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection.
Heidenreich A; Pfister D; Witthuhn R; Thüer D; Albers P
Eur Urol; 2009 Jan; 55(1):217-24. PubMed ID: 18926622
[TBL] [Abstract][Full Text] [Related]
24. Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients.
Cheney SM; Andrews PE; Leibovich BC; Castle EP
BJU Int; 2015 Jan; 115(1):114-20. PubMed ID: 24825773
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
Djaladat H; Nichols C; Daneshmand S
Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993
[TBL] [Abstract][Full Text] [Related]
26. Postchemotherapy laparoscopic retroperitoneal lymph node dissection in nonseminomatous germ-cell tumor.
Calestroupat JP; Sanchez-Salas R; Cathelineau X; Rozet F; Galiano M; Smyth G; Kasraeian A; Barret E; Vallancien G
J Endourol; 2009 Apr; 23(4):645-50. PubMed ID: 19335332
[TBL] [Abstract][Full Text] [Related]
27. Primary robotic retroperitoneal lymph node dissection following orchiectomy for testicular germ cell tumors: a single-surgeon experience.
Supron AD; Cheaib JG; Biles MJ; Schwen Z; Allaf M; Pierorazio PM
J Robot Surg; 2021 Apr; 15(2):309-313. PubMed ID: 32572754
[TBL] [Abstract][Full Text] [Related]
28. Laparoscopic and open postchemotherapy retroperitoneal lymph node dissection in patients with advanced testicular cancer--a single center analysis.
Busch J; Magheli A; Erber B; Friedersdorff F; Hoffmann I; Kempkensteffen C; Weikert S; Miller K; Schrader M; Hinz S
BMC Urol; 2012 May; 12():15. PubMed ID: 22651395
[TBL] [Abstract][Full Text] [Related]
29. Retroperitoneal lymph node dissection after chemotherapy for germ cell tumours: is a full bilateral template always necessary?
Steiner H; Peschel R; Bartsch G
BJU Int; 2008 Aug; 102(3):310-4. PubMed ID: 18325053
[TBL] [Abstract][Full Text] [Related]
30. Laparoscopic Retroperitoneal Lymph Node Dissection as a Safe Procedure for Postchemotherapy Residual Mass in Testicular Cancer.
Faria EF; Neves HS; Dauster B; Machado RD; Magnabosco WJ; Muller RL; Santos AC; Tobias-Machado M
J Laparoendosc Adv Surg Tech A; 2018 Feb; 28(2):168-173. PubMed ID: 29215949
[TBL] [Abstract][Full Text] [Related]
31. Propensity-matched Analysis of Open Versus Robotic Primary Retroperitoneal Lymph Node Dissection for Clinical Stage II Testicular Cancer.
Chavarriaga J; Atenafu EG; Mousa A; Langleben C; Anson-Cartwright L; Jewett M; Hamilton RJ
Eur Urol Oncol; 2024 Jan; ():. PubMed ID: 38278693
[TBL] [Abstract][Full Text] [Related]
32. Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group.
Gerdtsson A; Thor A; Grenabo Bergdahl A; Almås B; Håkansson U; Törnblom M; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Sagstuen Haugnes H; Engen Andreassen K; Melsen Larsen S; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
Eur Urol Oncol; 2022 Apr; 5(2):235-243. PubMed ID: 33750683
[TBL] [Abstract][Full Text] [Related]
33. Post-chemotherapy Laparoscopic Retroperitoneal Lymph Node Dissection for Mixed Malignant Germ Cell Testicular Tumors.
Pickersgill NA; Raval NS; Kim EH; Black RG; Du K; Figenshau RS
Clin Genitourin Cancer; 2021 Jun; 19(3):273.e1-273.e5. PubMed ID: 33139148
[TBL] [Abstract][Full Text] [Related]
34. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
[TBL] [Abstract][Full Text] [Related]
35. Population-based analysis of cost and peri-operative outcomes between open and robotic primary retroperitoneal lymph node dissection for germ cell tumors.
Bhanvadia R; Ashbrook C; Bagrodia A; Lotan Y; Margulis V; Woldu S
World J Urol; 2021 Jun; 39(6):1977-1984. PubMed ID: 32797261
[TBL] [Abstract][Full Text] [Related]
36. Minimally invasive post-chemotherapy retroperitoneal lymph node dissection for nonseminoma.
Sharma P; Sverrisson EF; Zargar-Shoshtari K; Fishman MN; Sexton WJ; Dickinson SI; Spiess PE; Poch MA; Gilbert SM; Pow-Sang JM
Can J Urol; 2015 Aug; 22(4):7882-9. PubMed ID: 26267026
[TBL] [Abstract][Full Text] [Related]
37. Post-chemotherapy robotic bilateral retroperitoneal lymph node dissection using a novel single-dock technique.
Stout TE; Soni SD; Goh AC
J Robot Surg; 2016 Dec; 10(4):353-356. PubMed ID: 27460844
[TBL] [Abstract][Full Text] [Related]
38. Perioperative complications and oncological outcomes of post-chemotherapy retroperitoneal lymph node dissection in patients with germ cell cancer at two high-volume university centres in Switzerland - a retrospective chart review.
Notarfrancesco M; Fankhauser CD; Lorch A; Ardizzone D; Helnwein S; Hoch D; Hermanns T; Thalmann G; Beyer J
Swiss Med Wkly; 2023 Apr; 153():40053. PubMed ID: 37080191
[TBL] [Abstract][Full Text] [Related]
39. Robotic retroperitoneal lymph node dissection for primary and post-chemotherapy testis cancer.
Nason GJ; Kuhathaas K; Anson-Cartwright L; Jewett MAS; O'Malley M; Sweet J; Hansen A; Bedard P; Chung P; Hahn E; Warde P; Hamilton RJ
J Robot Surg; 2022 Apr; 16(2):369-375. PubMed ID: 33982173
[TBL] [Abstract][Full Text] [Related]
40. Post-chemotherapy robot-assisted retroperitoneal lymph node dissection for metastatic germ cell tumors: safety and perioperative outcomes.
Branger N; Bladou F; Verhoest G; Knipper S; Robert G; Bernhard JC; Beauval JB; Khaddad A; Mauger De Varennes A; Fléchon A; Walz J; Bageot AS; Doumerc N; Rouprêt M; Murez T;
World J Urol; 2023 Sep; 41(9):2405-2411. PubMed ID: 37507528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]